CUE 8-K 2026-09-21

Cue Biopharma, Inc. (CUE) 8-K dated 2026-09-21 — accession 0001193125-26-396094. This URL is the filing, not the CUE hub.

Cue Biopharma, Inc. (CUE) is a biotechnology company listed on US.

Cue Biopharma, Inc. filed a 8-K on 2026-09-21. Accession 0001193125-26-396094.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CUE revenue for 2025-12-31 was $27.5M. Net income was -$26.6M. Revenue was up 195.7% from 2024-12-31 to 2025-12-31. CUE currently screens at market cap $59.5M.

Not investment advice. The CUE SEC hub lists recent forms. The stock page is the research view.